Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
European Bioinformatics Services European Bioinformatics Services
The European Bioinformatics Services Market, by increasing funding by government and private organization, was pegged at $ 297 million in 2012 and expected to be $ 806 million by 2018, growing at a CAGR of 21% from 2012 to 2018. The report “The European Bioinformatics Services Market forecast, 2012-2018” analyzes the Bioinformatics Services market into Data Analysis, Sequencing Services, Database & Management and others. The report also provides an extensive competitive landscaping of companies operating in Bioinformatics Services market include Accelrys Inc., Affymetrix Inc., Life Technologies Corporation, Illumina Inc. and CLC bio.
Upcoming
Asia-Pacific Bioinformatics Services Asia-Pacific Bioinformatics Services
The Asia-Pacific Bioinformatics Services Market, by increasing funding by government and private organization, was pegged at $ 121.8 million in 2012 and expected to be $ 573.49 million by 2018, growing at a CAGR of 24.7% from 2012 to 2018. The report “The Asia-Pacific Bioinformatics Services Market forecast, 2012-2018” analyzes the Bioinformatics Services market into Data Analysis, Sequencing Services, Database & Management and others. The report also provides an extensive competitive landscaping of companies operating in Bioinformatics Services market include Accelrys Inc., Affymetrix Inc., Life Technologies Corporation, Illumina Inc. and CLC bio.
Upcoming
Asian Basic Wound Care Market Asian Basic Wound Care Market
The Asian Basic Wound Care Market was valued at $71 million in 2013 and is expected to reach $83 million by 2018, at a CAGR of 3.2%. The report “Asian Basic Wound Care Market forecast, 2012-2018" analyzes the market of Basic Wound Care by 3 segments such as Tapes, Dry dressings and Cleansing solutions. The main companies operating in this market and extensively covered in this report are Derma Sciences, Smith & Nephew, 3M healthcare, Johnson and Johnson, Covidien, Molnlycke healthcare and others.
Upcoming
European Basic Wound Care Market European Basic Wound Care Market
The European Basic Wound Care Market was valued at $114 million in 2013 and is expected to reach $121 million by 2018, at a CAGR of 1.4%. The report “European Basic Wound Care Market forecast, 2012-2018" analyzes the market of Basic Wound Care by 3 segments such as Tapes, Dry dressings and Cleansing solutions. The main companies operating in this and extensively covered in this report are Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare, Smith & Nephew, 3M healthcare and others.
Upcoming
North American Basic Wound Care Market North American Basic Wound Care Market
The North American Basic Wound Care Market was valued at $346 million in 2013 and is expected to reach $376 million by 2018, at a CAGR of 2%. The report “North American  Basic Wound Care Market forecast, 2012-2018" analyzes the market of Basic Wound Care by 3 segments such as Tapes, Dry dressings and Cleansing solutions. The main companies operating in basic wound care market and extensively covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien, Molnlycke healthcare and others.
Upcoming
North American High Content analysis/Screening North American High Content analysis/Screening
The North American High Content Screening market was valued at $161.8 million in 2013 and is expected to reach $280.7 million by 2018, growing at a CAGR of 11.7% from 2013 to 2018. High Content Screening market segmentation primarily based on product types, the market is categorized into instruments (Imaging and Analysis HCS Systems, Flow Cytometers), consumables (Reagents and Assay kits, Microplates and other consumables) , software, and services. Based on applications, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, and compound profiling. Among the various end users of high content screening, pharmaceutical and biotechnology companies lead the market. Major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), PerkinElmer (U.S.), and GE Healthcare (U.K), Olympus (Japan), Life Technologies (U.S.), EMD Millipore (Germany), BD Bioscience (U.S.), Definiens AG (Germany), Yokogawa Electric Corporation (Japan), and TTP Labtech (U.S).
Upcoming
European High content analysis/Screening European High content analysis/Screening
The European High Content Screening market was valued at $124.29 million in 2013 and is expected to reach $207.9 million by 2018, growing at a CAGR of 10.6% from 2013 to 2018. High Content Screening market segmentation primarily based on product types, the market is categorized into instruments (Imaging and Analysis HCS Systems, Flow Cytometers), consumables (Reagents and Assay kits, Microplates and other consumables) , software, and services. Based on applications, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, and compound profiling. Among the various end users of high content screening, pharmaceutical and biotechnology companies lead the market. Major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), PerkinElmer (U.S.), and GE Healthcare (U.K), Olympus (Japan), Life Technologies (U.S.), EMD Millipore (Germany), BD Bioscience (U.S.), Definiens AG (Germany), Yokogawa Electric Corporation (Japan), and TTP Labtech (U.S).
Upcoming
North American Oral Drug Delivery Market North American Oral Drug Delivery Market
The North American Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $29.0 billion in 2013 and expected to be $43.7 billion by 2018, growing at a CAGR of 8.6%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
Asian High content analysis/Screening Asian High content analysis/Screening
The Asian High Content Screening market was valued at $55.75 million in 2013 and is expected to reach $101.74 million by 2018, growing at a CAGR of 12.8% from 2013 to 2018.High Content Screening market segmentation primarily based on product types, the market is categorized into instruments (Imaging and Analysis HCS Systems, Flow Cytometers), consumables (Reagents and Assay kits, Microplates and other consumables) , software, and services. Based on applications, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, and compound profiling. Among the various end users of high content screening, pharmaceutical and biotechnology companies lead the market. Major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), PerkinElmer (U.S.), and GE Healthcare (U.K), Olympus (Japan), Life Technologies (U.S.), EMD Millipore (Germany), BD Bioscience (U.S.), Definiens AG (Germany), Yokogawa Electric Corporation (Japan), and TTP Labtech (U.S).
Upcoming
European Oral Drug Delivery Market European Oral Drug Delivery Market
The European Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $16.9 billion in 2013 and expected to be $24.6 billion by 2018, growing at a CAGR of 7.7%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
Asian Oral Drug Delivery Market Asian Oral Drug Delivery Market
The Asian Oral Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies on in-house capabilities for the development of oral drug delivery technologies.The Market was Valued at $10.9 billion in 2013 and expected to be $19.8 billion by 2018, growing at a CAGR of 12.7%. The Oral Drug Delivery Market analyzes the market by segments such as Controlled Release, ODT and Taste Masking, Other Oral drug delivery technologies. The prominent players in the Market are Aptalis Pharmaceutical Technologies, Sky Pharma PLC, Tapemark, Baxter International Inc., Hovione Ltd.
Upcoming
North American High throughput screening North American High throughput screening
The North American High Throughput Screening market was valued at $6454.3 million in 2013 and is expected to reach $9046.8 million by 2018, growing at a CAGR of 7.0% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
European High throughput screening European High throughput screening
The European High Throughput Screening market was valued at $3794.7 million in 2013 and is expected to reach $5194.3 million by 2018, growing at a CAGR of 6.5% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
Asian High throughput screening Asian High throughput screening
The Asian High Throughput Screening market was valued at $2547.3 million in 2013 and is expected to reach $3931.2 million by 2018, growing at a CAGR of 9.1% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland).
Upcoming
North American Transdermal Drug Delivery Systems Market North American Transdermal Drug Delivery Systems Market
The North American Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $7.6 billion in 2013 and expected to be $12.7 billion by 2018, growing at a CAGR of 10.9%. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
European Transdermal Drug Delivery Systems Market European Transdermal Drug Delivery Systems Market
The European Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $3.6 billion in 2013 and expected to be $5.8 billion by 2018, growing at a CAGR of 9.9 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
Asian Transdermal Drug Delivery Systems Market Asian Transdermal Drug Delivery Systems Market
The Asian Transdermal Drug Delivery Market is mainly driven by patent cliffs and increased incidence of chronic diseases, increasing competition and improving patient compliance, and reformulation and repositioning of drugs using advanced oral delivery systems, huge investment made by big pharmaceutical companies.The Market was Valued at $1.5 billion in 2013 and expected to be $3.0 billion by 2018, growing at a CAGR of 14.8 %. The Transdermal Drug Delivery Market analyzes the market by segments such as Active Transdermal Drug Delivery, and Passive Transdermal Drug Delivery. The prominent players in this Market are Novartis, Johnson & Johnson, 3M Company, Noven.
Upcoming
North American Clinical Trial Management Systems (CTMS) Market North American Clinical Trial Management Systems (CTMS) Market
The North American Clinical Trial Management Systems Market is mainly driven by increasing R&D investment in pharmaceutical, life science and clinical research industries, Integration of CTMS with HIS, and rising prevalence of diseases and increased clinical research outsourcing.The Market was valued at $548.32 million in 2013 and expected to be $1107.57 million by 2018, growing at a CAGR of 15%. The Clinical Trial Management Systems Market analyzes the market by 2 segments such as Enterprise CTMS, and Site CTMS.The prominent players in the Clinical Trial Management Systems Market are Oracle Corporation, Perceptive Informatics (PAREXEL), Medidata Solutions, eResearch Technology Solutions, Bioclinica, Datatrak international inc., Pharmaceutical Product Development, LLC.
Upcoming
European Clinical Trial Management Systems (CTMS) Market European Clinical Trial Management Systems (CTMS) Market
The European Clinical Trial Management Systems Market is mainly driven by increasing R&D investment in pharmaceutical, life science and clinical research industries, Integration of CTMS with HIS, and rising prevalence of diseases and increased clinical research outsourcing.The Market was valued at $242.9 million in 2013 and expected to be $466 million by 2018, growing at a CAGR of 13.9%. The Clinical Trial Management Systems Market analyzes the market by 2 segments such as Enterprise CTMS, and Site CTMS.The prominent players in the Clinical Trial Management Systems Market are Oracle Corporation, Perceptive Informatics (PAREXEL), Medidata Solutions, eResearch Technology Solutions, Bioclinica, Datatrak international inc., Pharmaceutical Product Development, LLC.
Upcoming
Asian Clinical Trial Management Systems (CTMS) Market Asian Clinical Trial Management Systems (CTMS) Market
The Asian Clinical Trial Management Systems Market is mainly driven by increasing R&D investment in pharmaceutical, life science and clinical research industries, Integration of CTMS with HIS, and rising prevalence of diseases and increased clinical research outsourcing.The Market was valued at $63.8 million in 2013 and expected to be $133.9 million by 2018, growing at a CAGR of 16%. The Clinical Trial Management Systems Market analyzes the market by 2 segments such as Enterprise CTMS, and Site CTMS.The prominent players in the Clinical Trial Management Systems Market are Oracle Corporation, Perceptive Informatics (PAREXEL), Medidata Solutions, eResearch Technology Solutions, Bioclinica, Datatrak international inc., Pharmaceutical Product Development, LLC.
Upcoming
2987 reports | Show
Connect With Us
US/CAN : +1-888-502-0539